23rd May 2025 Plain language summary: Real-world outcomes of SDZ ETN (etanercept biosimilar) treatment for rheumatic diseases in the COMPACT study
17th Mar 2025 A plain language summary of the combined safety findings of adalimumab-adbm from the VOLTAIRE clinical trials in individuals with rheumatoid arthritis, Crohn’s disease, and chronic plaque psoriasis
